Valeant Pharmaceuticals reported $816M in EBITDA for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Aurora Cannabis Inc ACB:CN -71528000 45.57M
Canopy Growth Corp WEED:CN C$ -81888000 102.18M
Corcept Therapeutics CORT:US $ 36.95M 0.45M
Nektar Therapeutics NKTR:US $ -109.47M 0.5M
Valeant Pharmaceuticals VRX:CN $ 816M 17M
Zoetis ZTS:US $ 714M 131M